SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas joins a Venture Capital Panel at Mid-Atlantic Bio on September 28 in Bethesda, MD.
News | 08. 20. 2012
Art Pappas joins a Venture Capital Panel at Mid-Atlantic Bio on September 28 in Bethesda, MD.
